3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
7
Kidney Neoplasms
2
Urolithiasis
1
Stomatitis
1
Pneumoperitoneum
1
Neoplasm Metastasis
1
Lower Urinary Tract Symptoms
1
Invasive Bladder Cancer
1
Hydronephrosis
1
Gastrointestinal Stromal Tumors
1
Castrate-Resistant Prostate Cancer
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Interventions
tremelimumab
1
durvalumab
1
Sodium Chloride
1
Radiotherapy
1
Lidocaine
1
Hyperthermic Intraperitoneal Chemotherapy
1
Cystectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Invasive Bladder Cancer
×
Sodium Chloride
×
Genitourinary
×
Clear all
NCT02924480
2022-03-09
Lidocaine
CAMC Health System
Phase NA
Completed
50 enrolled